期刊文献+

社区获得性重症肺炎病原菌分布与耐药性分析 被引量:7

Distribution and drug resistance of pathogens causing community-acquired pneumonia
原文传递
导出
摘要 目的了解社区获得性重症肺炎(SCAP)常见病原菌分布及其耐药性,为临床合理使用抗菌药物提供依据。方法 2006年7月-2013年7月134例SCAP住院患者于入院第1天采集痰液标本,对其分离的病原菌进行鉴定和药物敏感性试验,将结果进行分析。结果 7年调查1 610例患者,发生SCAP134例,发生率8.3%;共分离出病原菌34株,排前3位的病原菌依次为肺炎链球菌、流感嗜血菌、金黄色葡萄球菌,分别占35.5%、20.6%、17.6%;肺炎链球菌对莫西沙星较为敏感,对万古霉素敏感性为100.0%。结论 SCAP感染病原菌以肺炎链球菌为主,对多种抗菌药物耐药现象严重,临床应合理使用抗菌药物。 OBJECTIVE To understand the distribution and drug resistance of common pathogens causing communi‐ty‐acquired pneumonia so as to provide guidance for reasonable clinical use of antibiotics .METHODS A total of 134 patients with community‐acquired pneumonia who were hospitalized from Jul 2006 to Jul 2013 were enrolled in the study ,the sputum specimens were collected on the first day of admission to the hospital ,then the isolated patho‐gens were identified ,the drug susceptibility testing was performed ,and the results were analyzed .RESULTS Of totally 1610 patients investigated in the 7 years ,the community‐acquired pneumonia occurred in 134 cases ,with the incidence rate of 8 .3% .A total of 34 strains of pathogens have been isolated ,among which the Streptococcus pneumoniae ,Haemophilus influenzae ,and Staphylococcus aureus ranked the top three species ,accounting for 35 .5% ,20 .6% ,and 17 .6% ,respectively .The S .pneumoniae was highly susceptible to moxifloxacin ,and the drug susceptibility rate to vancomycin was 100 .0% .CONCLUSION The S .pneumoniae is the predominant species of pathogen causing community‐acquired pneumonia and is highly resistant to a variety of antibiotics .It is necessa‐ry for the hospital to reasonably use antibiotics .
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2015年第5期990-991,1000,共3页 Chinese Journal of Nosocomiology
基金 广东省科技计划基金资助项目(2012B031800327) 广州市医药卫生科技基金资助项目(20131A011020)
关键词 社区获得性重症肺炎 病原菌 抗菌药物 耐药率 Community-acquired pneumonia Pathogen Antibiotic Drug resistance rate
  • 相关文献

参考文献5

  • 1Singanayagam A,Chalmers JD,Hin AT. Severity assessment in community-acquired pneumonia: a review[J]. QJM,2009, 102(6) : 379-388.
  • 2Mandell LA, Wunderink RG, Anzueto A, et al. Infectious diseases society of america/american thoracic society consensus guidelines on the management of community-acquired pneumonia in adults [J]. Clin Infect Dis,2007,44(Suppl) :$27-72.
  • 3易慧,谢灿茂.重症肺炎临床及预后因素分析[J].中华医院感染学杂志,2008,18(1):56-58. 被引量:106
  • 4Suberviola B,Castellanos-Ortega A,Llorca J,etal. Prognos- tic value of proadrenomedullin in severe sepsis and septic sb, oek patients with community-acquired pneumonia[J]. Swiss Med Wkly,2012,54(8) :1126-1133.
  • 5Prez-TralleroE, Martin-HerreroJE, Maz6nA, et al. Antimi- erobial resistance among respiratory pathogens in Spain: lat- est data and changes over 11 years (1996-1997 to 2006-2007)[J]. Antimierob Agents Chemother, 2010, 54 (7) : 2953- 2959.

二级参考文献12

  • 1牟小芬,张进川,夏文俊.长期机械通气的老年患者医院内肺部感染的调查[J].中华医院感染学杂志,2006,16(5):500-502. 被引量:18
  • 2孙树梅,李琼,王茵茵,张亚莉,汪能平.发生呼吸机相关性肺炎的高危因素及病原菌分析[J].中华医院感染学杂志,2006,16(8):882-884. 被引量:87
  • 3[1]American Thoracic Society.Guidelines for the management of adults with community acquired pneumonia[J].Am J Crit Care Med,2001,163(7):1730-1754.
  • 4[2]American Thoracic Society,Infectious Diseases Society of America.Guidelines for the management of adults with hospital-acquired,ventilator-associated,and healthcare-associated pneumonia[J].Am J Respir Crit Care,2005,171(4):388-416.
  • 5[3]Paganin F,Lilienthal F,Bourdin A,et al.Severe community-acquired pneumonia:assessment of microbial aetiology as mortality factor[J].Eur Respir J,2004,24(5):779-785.
  • 6[4]Rello J,Bodi M,Mariscal D,et al.Microbiological testing and outcome of patients with severe community-acquired pneumonia[J].Chest,2003,123(1):174-180.
  • 7[7]Valles J,Mesalles E,Mariscal D,et al.A 7-year study of severe hospital-acquired pneumonia requiring ICU admission[J].Intensive Care Med,2003,29(11):1981-1988.
  • 8[8]Wilson PA,Ferguson J.Severe community-acquired pneumonia:an Australian perspective[J].Intern Med J,2005,35(12):699-705.
  • 9[9]Martinez JA,Horcajada JP,Almela M,et al.Addition of a macrolide to a β-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia[J].Clin Infect Dis,2003,36(4):389-395.
  • 10[10]Baddour LM,Yu VL,Klugman KP,et al.Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia[J].Am J Respir Crit Care Med,2004,170(4):440-444.

共引文献105

同被引文献53

  • 1Rocca YS, Roberti MP, Arriaga JM, et al. Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients [J ]. Innate Immun, 2013,19( 1 ) : 76-85.
  • 2Jason W. Common questions about infectious mononucleosis [J]. Am Faro Physician,2015,91 (6): 372-377.
  • 3Houck PM,Bratzler DW,Nsa W,er al.Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community acquired pneumonia[J]. Arch Intern Med,2004,164(3):637.
  • 4Paran D,Fireman E,Elkayam O.Pulmonary disease in systemic lupus erythematosus and antiphosphopid syndrome[J]. AutoimmunRev,2004,3(l):70-75.
  • 5Swigris JJ,Fischer A,Gilles J,et al.Pulmonary and thrombotic manifestations of systemic lupus erythematosus[J]. Chest,2008,133(l):271.
  • 6Raj R,Murin S,Matthay RA,et al.Systemic lupus erythematosus in the intensive care unit[J]. Crit Care Clin,2002,18(4):781-803.
  • 7龙腾河,农村立,郭堑,廖明壮,罗焕江.脓毒性肺栓塞的MSCT诊断价值[J].临床放射学杂志,2010,29(8):1058-1061. 被引量:4
  • 8方明,孔繁荣.肺炎克雷伯杆菌肺炎的CT诊断[J].青岛大学医学院学报,2013,49(1):83-84. 被引量:7
  • 9陆卫华,杨剑虹,方庆,李刚,唐忠志.老年重症肺炎行机械通气患者病原菌分布及耐药率分析[J].西南国防医药,2013,23(4):372-374. 被引量:9
  • 10汤正珍,李文莲,黄波.遵义地区婴幼儿重症肺炎细菌病原学分析[J].中国微生态学杂志,2013,25(7):826-829. 被引量:3

引证文献7

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部